← All diseases Infectious diseases

Chronic hepatitis C

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (76)Meta-analysis (20)Treatment guideline (4)Phase 3 study (24)Randomized trial (14)Systematic review (14)Clinical trial (680)Review article (146)Early study (phase 1 or 2) (11)Case report (85)Laboratory or animal study (8)Commentary or editorial (53)Retracted publication (2) Studies currently recruiting participants only (15)

Filter

Publications and studies (1942)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Unilateral adrenal metastases as an unusual primary presentation of hepatocellular carcinoma: a case report and literature review. (2024/08/14) ♡
• Potential role of Vitamin D in immune response in patients with viral hepatitis. (2024/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Modified by the Innovative Drugs and Strategies-Pattern of Selected Indications for Pediatric Liver Transplantation. (2024/08/01) ♡
• Effects of N-acetylcysteine on hepatocellular carcinoma in chronic hepatitis C. (2024/07/15) ♡
• Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030. (2024/07/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. EVALUATION OF PREDICTORS OF INEFFECTIVENESS OF ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C IN THE REPUBLIC OF KAZAKHSTAN: A MATCHED CASE-CONTROL STUDY. (2024/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful management of hepatitis B and C coinfection: a case report. (2024/07/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. MANAGEMENT OF EROSIVE ORAL LICHEN PLANUS ASSOCIATED WITH CHRONIC HEPATITIS C. (2024/07/01) ♡
• Sex-based Disparities in Liver Transplantation for Hepatocellular Carcinoma and the Impact of the Growing Burden of NASH. (2024/06/20) ♡
• Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus. (2024/06/01) ♡
• Agreement and diagnostic differences among three definitions of sarcopenia in patients with chronic hepatitis C. (2024/06/01) ♡
• Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Sofosbuvir-velpatasvir in children 3-17 years old with hepatitis C virus infection. (2024/06/01) ♡
• Causal associations between chronic viral hepatitis and psychiatric disorders: a Mendelian randomization study. (2024/05/31) ♡
• Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. (2024/05/10) ♡
• Comparison of postoperative outcomes in cases achieving sustained virological response with direct-acting antiviral and interferon therapy. (2024/05/01) ♡
• Antiviral Treatment and Response are Associated With Lower Risk of Dementia Among Hepatitis C Virus-Infected Patients. (2024/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Adherence in Hepatitis C Virus Treatment: What We Know. (2024/05/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Integrated Hepatitis C-Opioid Use Disorder Care Through Facilitated Telemedicine: A Randomized Trial. (2024/04/23) ♡
• Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age-period-cohort model for estimating demand from antecedent anti-HCV survey. (2024/04/01) ♡
• Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort. (2024/04/01) ♡
• Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis. (2024/04/01) ♡
• Factors associated with prior completion of colorectal cancer and hepatitis C virus screenings among community health center patients: a cross-sectional study to inform a multi-behavioral educational intervention. (2024/04/01) ♡
• VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response. (2024/04/01) ♡
• ESPGHAN recommendations on treatment of chronic hepatitis C virus infection in adolescents and children including those living in resource-limited settings. (2024/04/01) ♡
• The Efficacy of On-Site Integration Screening and Microelimination Programs for Chronic Hepatitis C in a Detection Center: A Comparison of the Treatment Outcomes and Characteristics of Incarcerated Patients and Outpatients. (2024/03/13) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Extrahepatic manifestations of HCV where do we stand? (2024/03/08) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Potential of Anti-coronavirus Plant Secondary Metabolites in COVID-19 Drug Discovery as an Alternative to Repurposed Drugs: A Review. (2024/03/01) ♡
• Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care. (2024/03/01) ♡
• Hepatitis C virus cure from direct-acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort). (2024/03/01) ♡
• Effect of previous infection with hepatitis B virus on the incidence of hepatocellular carcinoma after sustained virologic response in patients with chronic hepatitis C virus infection. (2024/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Clinical diagnosis of viral hepatitis: Current status and future strategies. (2024/03/01) ♡
• Clinical significance of CDT1 mRNA expression in chronic hepatitis C or liver cirrhosis. (2024/03/01) ♡
• Impact of amino acid substitutions in hepatitis C virus core region on the severe oxidative stress. (2024/02/20) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Updated Clinical Guidelines on the Management of Hepatitis C Infection in Children. (2024/02/16) ♡
• Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment. (2024/02/14) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatitis C virus micro-elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide. (2024/02/01) ♡
• Excellent hepatitis C virus cure rates despite increasing complexity of people who use drugs: Integrated-Test-stage Treat study final outcomes. (2024/02/01) ♡
• Mortality related to HCV and other chronic liver diseases in Veneto (Italy), 2008-2021: Changes in trends and age-period-cohort effects. (2024/02/01) ♡
• Sex-related difference analyses of efficacy and safety in clinical trials of direct-acting antivirals to treat chronic HCV genotype 1 and 3 infections. (2024/02/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A systematic analysis of anthocyanins inhibiting human, murine, and equine herpesviruses. (2024/02/01) ♡
• Depth effect on point shear wave velocity elastography: Evidence in a chronic hepatitis C patient cohort. (2024/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention. (2024/01/24) ♡
• Carbonized aerogel/ZnO-based dispersive solid phase extraction of daclatasvir and sofosbuvir from biological samples prior to liquid chromatography-tandem mass spectrometry. (2024/01/20) ♡
• Ser235 phosphorylation of hepatitis C virus NS5A is required for NS5A dimerization and drug resistance. (2024/01/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Therapeutic approaches for chronic hepatitis C: a concise review. (2024/01/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence. (2024/01/11) ♡
• Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations. (2024/01/03) ♡
• 'We've got a present for you': Hepatitis C elimination, compromised healthcare subjects and treatment as a gift. (2024/01/01) ♡
• Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels. (2024/01/01) ♡
• Towards elimination of hepatitis C in Oslo: Cross-sectional prevalence studies among people who inject drugs. (2024/01/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.